The pharmaceutical company Merck, which sells the anti-bone-loss drug Fosamax, estimated in 2003, from its own market research, that about 8 million women had been found to have osteopenia and about a third of them were taking an osteoporosis drug.
About 8 million women had been found to have osteopenia. This was what the pharmaceutical company Merck estimated in 2003, from its own market research. About a third of them were taking an osteoporosis drug. This was what the pharmaceutical company Merck estimated in 2003, from its own market research. The pharmaceutical company Merck sells the anti-bone-loss drug Fosamax.